February 11, 2005 -- ViaCell is a recent biotech IPO, the first--and most successful--of several biotechs to make their trading debuts this year. The company is involved in biotech’s hottest sector, stem cells, with an unusual business plan that includes a revenue producing division. We profile ViaCell, its drug candidates, finances and business plan...
